Combination Products and EU MDR 2017/745 Regulation
Combination products will undergo to a substantial change under the EU MDR 2017/745 and new regulatory challenges are at the horizon. Drug-device combinations (DDC) became an essential tool for
Combination products will undergo to a substantial change under the EU MDR 2017/745 and new regulatory challenges are at the horizon. Drug-device combinations (DDC) became an essential tool for
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.